Current Coverage Archives - Vista Partners LLC

Federal Initiatives Spur GeoVax’s American-Made Biotech Pipeline -( $GOVX $IBB $XBI )

by Vista Partners LLC October 31, 2025 234Views 0Likes

GeoVax Labs (NASDAQ: GOVX), a clinical-stage biotechnology company, has recently sharpened its focus on addressing urgent global health threats through advanced vaccine development and manufacturing strategies. Since October, the Atlanta-based firm has released a series of statements highlighting regulatory wins, key interim…

Inside the Obesity Drug Gold Rush: Eli Lilly’s Rise and a New Era for Insulin Patches ( $ABT $LLY $BBNX $MODD )

by Vista Partners LLC October 30, 2025 160Views 0Likes

Eli Lilly’s (LLY) relentless push into obesity and diabetes therapeutics is reshaping the future of metabolic health—and igniting a wave of innovation among smaller device makers intent on redefining patient care at home. Building on strong demand for its blockbuster weight-loss and…

Inside Nokia’s Comeback: How AI and Cloud Partnerships Sparked Double-Digit Growth -( $NOK $SPY $NVDA )

by Vista Partners LLC October 23, 2025 144Views 0Likes

Nokia’s (NOK, $6.11, +37.85% YTD) latest earnings report suggests the Finnish telecom and technology company is undergoing one of its most compelling transformations in years—pivoting decisively toward AI infrastructure and cloud networking as new revenue engines drive growth and boost investor confidence.…

Sunnyvale’s Intuitive Surgical Lifts Outlook as Robotic-Surgery Demand Surges -( $ISRG $SPY )

by Vista Partners LLC October 22, 2025 99Views 0Likes

Intuitive Surgical (NASDAQ: ISRG) delivered a striking third quarter, sending its shares surging 17% on Wednesday and underscoring both the company’s operational strength and the accelerating global embrace of robotic-assisted healthcare. The Sunnyvale, California-based leader in minimally invasive surgery reported quarterly revenue…

Serina Therapeutics CEO Video Unveils FDA Alignment Advancing Parkinson’s Therapy -( $SER $IBB $XBI )

by Vista Partners LLC October 22, 2025 123Views 0Likes

Serina Therapeutics (NYSE American: SER) CEO Steven A. Ledger shared encouraging insights in a recent video presentation about the company’s accelerated FDA regulatory pathway for its lead asset, SER-252, targeting advanced Parkinson’s disease. The video can be viewed here: Serina CEO FDA Alignment…

How Alkermes’ $2.1 Billion Avadel Deal Could Reshape Sleep Disorder Treatments -( $ALKS $AVDL $IBB $XBI )

by Vista Partners LLC October 22, 2025 110Views 0Likes

Alkermes (ALKS) is making a bold entry into the sleep disorders market with the acquisition of Avadel Pharmaceuticals, a deal valued at up to $2.1 billion. This strategic move gives Alkermes access to LUMRYZ, a once-nightly, FDA-approved treatment for narcolepsy, and sets…

Japanese Pharmaceutical Giant Takeda Bets $11.4 Billion on China’s Innovent to Fuel Next-Gen Cancer Drug Pipeline – ( $TAK $IBB $XBI )

by Vista Partners LLC October 22, 2025 110Views 0Likes

Japanese pharmaceutical giant Takeda Pharmaceutical (TAK) has entered into one of the industry's largest licensing agreements this year, committing up to $11.4 billion to acquire rights to three next-generation cancer therapies from China's Innovent Biologics in a deal that underscores the growing…

Tesla’s Next Move: AI-Focused Future Looms Large Ahead of Q3 Earnings – ( $TSLA $SPY )

by Vista Partners LLC October 22, 2025 143Views 0Likes

Tesla (TSLA) is set to report its third-quarter 2025 earnings today, a report that could serve as a major inflection point for the world’s most prominent electric-vehicle maker. Analysts anticipate revenue near 26.3 billion dollars and earnings per share (EPS) of roughly…

Hologic’s $18B Sale to Blackstone, TPG Underscores Private Equity’s Push Into Women’s Health -( $BX $HOLX $TPG )

by Vista Partners LLC October 21, 2025 100Views 0Likes

Blackstone (BX) and TPG (TPG) are taking women’s health leader Hologic Inc. (HOLX) private in one of the largest healthcare buyouts of 2025, valuing the Massachusetts-based company at up to $18.3 billion including debt. The all-cash deal, announced Tuesday, will pay Hologic…

Three Scientists Win Nobel for Unlocking the Immune System’s Self-Control – ( $IBB $XBI )

by Vista Partners LLC October 16, 2025 78Views 0Likes

A Discovery That Redefined Immunity The 2025 Nobel Prize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi for breakthroughs that revealed how the immune system prevents itself from turning on the body—a discovery that…

Current Coverage

Your Guide To Staying Informed In The Markets